News

Snowdon is a biopharmaceutical company that specialises in the discovery and development of novel small-molecule therapeutics for the treatment of pain, infectious diseases and nervous system disorders Snowdon

EUSA Pharma submitted its Erwinase BLA on a rolling basis, following receipt of Fast Track designation from the FDA. EUSA Pharma’s completed BLA submission requests Priority Review status,

Unigene Laboratories designs, manufactures and develops peptide-based therapeutics. The company is building a portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence platform. Unigene

Biosof claims that PubSeq is a novel scientific knowledge management system capable of mining the scientific literature for meaningful, accurate and relevant data. The award was made through

A5 Labs said that the custom-made LIMS system will allow its CRO customers to track and receive real-time information on the progress and status of the analysis of

Medidata Solutions has posted a net income of $4.66m for the third quarter 2010, or $0.2 per diluted share, compared to net income of $1.55m, or $0.06 per

XenoPort has posted a net loss of $19.9m for the third quarter 2010, or $0.65 loss per diluted share, compared to a net loss of $24.37m, or $0.81

The QTDP program was created by Congress as part of the Patient Protection and Affordable Care Act of 2010. NovaBay is a clinical stage biotechnology company focused on

Burris, who will join the company in this capacity on 3 January 2011, is currently a member of the board of directors of OncoGenex. Most recently, Burris worked